As per the terms of the agreement, Sun Pharma will be the exclusive development and commercialisation partner for Triferic during the term of the agreement, subject to its approval in India.
Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in India
More from Industry NewsMore posts in Industry News »
- FDA panel endorses booster shot for J&J Covid-19 vaccine
- Intas launches the World’s first SB-100mg Itraconazole
- Second J&J COVID-19 shot gets expert backing; FDA is looking at lowering age for Pfizer booster
- StayHappi pharmacy enters Assam with 70 stores
- Mumbai: Larger ITAT bench to rule on pharma freebies